Tronox’s (TROX) Buy Rating Reaffirmed at Alembic Global Advisors

Share on StockTwits

Alembic Global Advisors reissued their buy rating on shares of Tronox (NYSE:TROX) in a research note issued to investors on Monday, TipRanks reports. They currently have a $19.00 price target on the stock.

A number of other research analysts have also recently issued reports on TROX. Zacks Investment Research cut shares of Tronox from a buy rating to a hold rating in a research note on Friday, October 18th. TheStreet lowered Tronox from a c- rating to a d+ rating in a research report on Friday, October 11th. BMO Capital Markets set a $18.00 price target on Tronox and gave the stock a buy rating in a research report on Monday, August 12th. Finally, ValuEngine cut Tronox from a hold rating to a sell rating in a report on Tuesday, November 19th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of Hold and a consensus target price of $14.64.

TROX opened at $11.44 on Monday. The firm has a market cap of $1.66 billion, a price-to-earnings ratio of 20.43 and a beta of 3.50. The company has a debt-to-equity ratio of 3.80, a quick ratio of 1.62 and a current ratio of 3.26. The firm’s 50-day simple moving average is $9.91 and its 200-day simple moving average is $9.90. Tronox has a twelve month low of $6.46 and a twelve month high of $15.50.

Tronox (NYSE:TROX) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.06. The firm had revenue of $768.00 million during the quarter, compared to the consensus estimate of $797.64 million. Tronox had a negative net margin of 4.79% and a positive return on equity of 6.56%. The firm’s quarterly revenue was up 68.4% on a year-over-year basis. During the same period last year, the firm posted $0.17 EPS. As a group, sell-side analysts anticipate that Tronox will post 0.45 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 2nd. Shareholders of record on Tuesday, November 19th were issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date of this dividend was Monday, November 18th. Tronox’s dividend payout ratio is currently 32.14%.

A number of large investors have recently modified their holdings of the business. Tower Research Capital LLC TRC bought a new position in shares of Tronox in the second quarter worth about $43,000. Quantum Capital Management bought a new stake in shares of Tronox during the third quarter valued at approximately $32,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Tronox by 26.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,882 shares of the company’s stock valued at $75,000 after purchasing an additional 1,244 shares in the last quarter. PARK CIRCLE Co acquired a new stake in shares of Tronox in the second quarter valued at approximately $96,000. Finally, FNY Investment Advisers LLC bought a new position in Tronox in the 2nd quarter worth approximately $108,000. 58.19% of the stock is currently owned by hedge funds and other institutional investors.

About Tronox

Tronox Holdings plc engages in the mining, production, and marketing of inorganic minerals and chemicals in North America, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It mines and processes titanium ore, zircon, and other minerals; and manufactures titanium dioxide pigments that add brightness and durability to paints, plastics, paper, and other everyday products.

Recommended Story: Yield Curve

Analyst Recommendations for Tronox (NYSE:TROX)

Receive News & Ratings for Tronox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tronox and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.